Management of Fetal Demise at 24 Weeks Gestation
For this patient with confirmed fetal demise at 24 weeks gestation, the answer is C: Misoprostol vaginal pessaries. This is the most effective, safest, and evidence-based approach for labor induction at this gestational age, with 100% success rates within 48 hours and significantly shorter induction-to-delivery intervals compared to oxytocin. 1, 2
Immediate Assessment Required
Before initiating any management, urgently assess for signs of intrauterine infection, as this is the leading cause of maternal death with fetal demise:
- Check for maternal tachycardia (do not wait for fever to develop) 1
- Examine for purulent cervical discharge 1
- Assess for uterine tenderness 1
- Monitor vital signs for early sepsis (maternal sepsis can progress to death within 18 hours of symptom onset) 3, 1
If any signs of infection are present, immediately start IV broad-spectrum antibiotics (ampicillin plus gentamicin, add clindamycin or metronidazole for anaerobic coverage) and proceed with urgent evacuation. 1
Why Misoprostol is the Correct Answer
Efficacy Data
Misoprostol vaginal pessaries achieve 100% success rates within 48 hours for fetal demise at this gestational age, with 66.7% delivering within 12 hours and 87.5% within 24 hours. 2 The mean induction-to-delivery interval is approximately 8.5-12.4 hours. 4, 5
Recommended Regimen
For gestations of 24-34 weeks, use intravaginal misoprostol 400 mcg every 3-6 hours. 1 Pretreatment with mifepristone 200 mg given 24-48 hours prior to misoprostol further optimizes cervical ripening and reduces induction time. 1, 4
Safety Profile
Misoprostol at this gestational age has an excellent safety profile with only 8.3% experiencing mild side effects and 3.1% requiring treatment for presumed or proven pelvic sepsis. 4 No cases of uterine tachysystole, hemorrhage, or coagulopathy were recorded in major studies. 4
Why NOT Oxytocin (Option A)
IV oxytocin is significantly less effective than misoprostol for fetal demise at 24 weeks. The mean induction-to-delivery interval with oxytocin is 23.3 hours compared to 12.4 hours with misoprostol (p=0.004). 5 At gestations before 28 weeks specifically, the induction-to-delivery interval with oxytocin is more than twice as long as with misoprostol. 5
Additionally, oxytocin is substantially more expensive (7.86 USD vs 0.65 USD for misoprostol) and requires continuous IV infusion with titration, making it less practical. 5
Why NOT D&C (Option B)
Dilation and curettage is inappropriate and unsafe at 24 weeks gestation. D&C is only suitable for first trimester losses (≤12-13 weeks). 1, 6 At 24 weeks, the fetal size and uterine dimensions make surgical evacuation via D&C technically impossible and extremely dangerous, with high risks of uterine perforation, hemorrhage, and incomplete evacuation. 6
The appropriate surgical method at this gestational age would be dilation and evacuation (D&E), but medical management with misoprostol remains the preferred first-line approach. 1
Critical Management Steps
Before Initiating Misoprostol
- Establish large-bore IV access 1
- Type and screen blood for potential hemorrhage 1
- Confirm Rh status (administer 300 μg Rh immunoglobulin IM within 72 hours if Rh-negative) 1, 6
- Rule out prior cesarean delivery (misoprostol is absolutely contraindicated due to 1-2% uterine rupture risk) 1
During Induction
- Monitor maternal vital signs continuously for tachycardia, fever, hypotension suggesting sepsis 1
- Monitor uterine activity to assess contraction pattern and avoid hyperstimulation 1
- No fetal heart rate monitoring required (fetus is deceased) 1
Post-Delivery
- Administer uterotonics (oxytocin, methylergonovine) to prevent postpartum hemorrhage 1
- Confirm complete expulsion with ultrasound before discharge (retained tissue dramatically increases infection risk) 1
Special Contraindication: Prior Cesarean Delivery
If this patient has a prior cesarean delivery, DO NOT use misoprostol under any circumstances. Instead, use oxytocin-based protocols or mechanical methods such as Foley catheter with extra-amniotic saline infusion. 1 The risk of uterine rupture with misoprostol in scarred uteri is 1-2%, which is unacceptably high. 1
Critical Pitfalls to Avoid
- Never use expectant management for confirmed fetal demise—active evacuation is always indicated due to infection and coagulopathy risks 1, 6
- Never delay treatment waiting for fever if other signs of infection are present 3, 1
- Never discharge the patient until complete expulsion is confirmed by ultrasound 1
- Never use misoprostol in women with prior cesarean delivery 1